SIMPLER HA THREADED, ST 5002-8, SIT 5002-8, ST 5011-ST5014, ST 5021-24
Device Facts
| Record ID | K060376 |
|---|---|
| Device Name | SIMPLER HA THREADED, ST 5002-8, SIT 5002-8, ST 5011-ST5014, ST 5021-24 |
| Applicant | Simpler Implant, Inc. |
| Product Code | DZE · Dental |
| Decision Date | Apr 25, 2006 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 872.3640 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
The Simpler HA Coated Threaded Dental Implants are endosseous threaded implants used as an artificial root structure to replace missing teeth. They are used to support crowns. bridges, or dentures in the maxilla or mandible area of the mouth.
Device Story
Simpler HA Coated Threaded Dental Implants function as artificial root structures for tooth replacement. Implants are surgically placed into the maxilla or mandible to provide support for prosthetic restorations including crowns, bridges, or dentures. Device is intended for use by dental professionals in a clinical setting. Benefit includes restoration of oral function and aesthetics for patients with missing teeth.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Endosseous threaded dental implant with Hydroxyapatite (HA) coating. Designed for placement in maxilla or mandible. Class II device under 21 CFR 872.3640.
Indications for Use
Indicated for patients requiring replacement of missing teeth in the maxilla or mandible. Used as artificial root structures to support crowns, bridges, or dentures.
Regulatory Classification
Identification
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
Special Controls
*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.